Rank | Gene Set | Z-score |
---|---|---|
1 | lymph vessel development (GO:0001945) | 7.55650938 |
2 | surfactant homeostasis (GO:0043129) | 7.14309887 |
3 | vascular endothelial growth factor signaling pathway (GO:0038084) | 6.72205364 |
4 | lymphangiogenesis (GO:0001946) | 6.68248875 |
5 | blood vessel maturation (GO:0001955) | 6.60206079 |
6 | positive regulation of vasculogenesis (GO:2001214) | 6.24591848 |
7 | regulation of endothelial cell differentiation (GO:0045601) | 6.21015414 |
8 | endothelium development (GO:0003158) | 5.93032716 |
9 | morphogenesis of an endothelium (GO:0003159) | 5.90963819 |
10 | endothelial tube morphogenesis (GO:0061154) | 5.90963819 |
11 | regulation of vasculogenesis (GO:2001212) | 5.82878136 |
12 | positive regulation of endothelial cell differentiation (GO:0045603) | 5.70886851 |
13 | chemical homeostasis within a tissue (GO:0048875) | 5.63525355 |
14 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.56744551 |
15 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 5.49517965 |
16 | angiogenesis involved in wound healing (GO:0060055) | 5.11920009 |
17 | endothelial cell differentiation (GO:0045446) | 4.78545277 |
18 | Notch signaling involved in heart development (GO:0061314) | 4.64799005 |
19 | basement membrane organization (GO:0071711) | 4.41643679 |
20 | negative regulation of focal adhesion assembly (GO:0051895) | 4.40165787 |
21 | negative regulation of cell junction assembly (GO:1901889) | 4.40165787 |
22 | negative regulation of adherens junction organization (GO:1903392) | 4.40165787 |
23 | endothelial cell morphogenesis (GO:0001886) | 4.38933590 |
24 | regulation of blood vessel endothelial cell migration (GO:0043535) | 4.32077196 |
25 | cell migration involved in sprouting angiogenesis (GO:0002042) | 4.25882801 |
26 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 4.17437882 |
27 | blood vessel endothelial cell migration (GO:0043534) | 4.00224527 |
28 | negative regulation of endothelial cell proliferation (GO:0001937) | 3.91216500 |
29 | artery development (GO:0060840) | 3.89813934 |
30 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.88071152 |
31 | patterning of blood vessels (GO:0001569) | 3.87843619 |
32 | positive regulation of urine volume (GO:0035810) | 3.83274749 |
33 | vasculogenesis (GO:0001570) | 3.79276046 |
34 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.79147842 |
35 | renal filtration (GO:0097205) | 3.78769682 |
36 | negative regulation of angiogenesis (GO:0016525) | 3.72511637 |
37 | glomerular filtration (GO:0003094) | 3.71580018 |
38 | sprouting angiogenesis (GO:0002040) | 3.68774218 |
39 | venous blood vessel morphogenesis (GO:0048845) | 3.65574005 |
40 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 3.64034283 |
41 | heart trabecula morphogenesis (GO:0061384) | 3.63242050 |
42 | negative regulation of fibrinolysis (GO:0051918) | 3.63212900 |
43 | negative regulation of blood vessel morphogenesis (GO:2000181) | 3.57938077 |
44 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.56787972 |
45 | substrate-dependent cell migration (GO:0006929) | 3.52028965 |
46 | endothelial cell proliferation (GO:0001935) | 3.48501878 |
47 | wound healing, spreading of cells (GO:0044319) | 3.46171454 |
48 | embryonic heart tube development (GO:0035050) | 3.45196421 |
49 | heart trabecula formation (GO:0060347) | 3.41550067 |
50 | negative regulation of vasculature development (GO:1901343) | 3.40974312 |
51 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.40479590 |
52 | nephron epithelium development (GO:0072009) | 3.39210141 |
53 | negative regulation of platelet activation (GO:0010544) | 3.37471026 |
54 | trabecula morphogenesis (GO:0061383) | 3.36206356 |
55 | blood vessel remodeling (GO:0001974) | 3.35813657 |
56 | ovulation from ovarian follicle (GO:0001542) | 3.30450284 |
57 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.30233092 |
58 | axon extension involved in axon guidance (GO:0048846) | 3.25657986 |
59 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.25657986 |
60 | neuron remodeling (GO:0016322) | 3.25201965 |
61 | endothelial cell chemotaxis (GO:0035767) | 3.22155372 |
62 | regulation of cell-substrate junction assembly (GO:0090109) | 3.16363948 |
63 | regulation of focal adhesion assembly (GO:0051893) | 3.16363948 |
64 | negative regulation of endothelial cell migration (GO:0010596) | 3.16120010 |
65 | cAMP biosynthetic process (GO:0006171) | 3.10459932 |
66 | regulation of adherens junction organization (GO:1903391) | 3.10133092 |
67 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.09779103 |
68 | positive regulation of receptor recycling (GO:0001921) | 3.07886337 |
69 | lung vasculature development (GO:0060426) | 3.05804676 |
70 | positive regulation of focal adhesion assembly (GO:0051894) | 3.05471199 |
71 | positive regulation of cell junction assembly (GO:1901890) | 3.05471199 |
72 | cell adhesion mediated by integrin (GO:0033627) | 3.04317907 |
73 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.03982969 |
74 | positive regulation of odontogenesis (GO:0042482) | 3.03423663 |
75 | anatomical structure maturation (GO:0071695) | 3.01748282 |
76 | endothelial cell migration (GO:0043542) | 3.01029547 |
77 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 3.00920838 |
78 | regulation of epithelial cell migration (GO:0010632) | 2.99781401 |
79 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.99670204 |
80 | regulation of metalloenzyme activity (GO:0048552) | 2.99522042 |
81 | response to xenobiotic stimulus (GO:0009410) | 2.95763700 |
82 | regulation of fibrinolysis (GO:0051917) | 2.93453791 |
83 | positive regulation of epithelial cell migration (GO:0010634) | 2.92846415 |
84 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.91242368 |
85 | coronary vasculature morphogenesis (GO:0060977) | 2.89918886 |
86 | wound healing, spreading of epidermal cells (GO:0035313) | 2.89267685 |
87 | transcytosis (GO:0045056) | 2.88853521 |
88 | positive regulation of endothelial cell proliferation (GO:0001938) | 2.88617983 |
89 | hyaluronan catabolic process (GO:0030214) | 2.88324935 |
90 | midgut development (GO:0007494) | 2.86859590 |
91 | endochondral ossification (GO:0001958) | 2.86564738 |
92 | replacement ossification (GO:0036075) | 2.86564738 |
93 | positive regulation of adherens junction organization (GO:1903393) | 2.84598856 |
94 | mesodermal cell differentiation (GO:0048333) | 2.83934843 |
95 | definitive hemopoiesis (GO:0060216) | 2.83844294 |
96 | protein localization to endosome (GO:0036010) | 2.83100707 |
97 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.82140518 |
98 | regulation of endothelial cell proliferation (GO:0001936) | 2.82079266 |
99 | lung lobe morphogenesis (GO:0060463) | 2.80572624 |
100 | cellular response to nitric oxide (GO:0071732) | 2.80217554 |
101 | negative regulation of vascular permeability (GO:0043116) | 2.79956462 |
102 | respiratory tube development (GO:0030323) | 2.79055825 |
103 | regulation of endothelial cell migration (GO:0010594) | 2.77736257 |
104 | regulation of urine volume (GO:0035809) | 2.76910149 |
105 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.76202927 |
106 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.76125702 |
107 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.76060778 |
108 | regulation of glomerular filtration (GO:0003093) | 2.72408284 |
109 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.72230520 |
110 | membrane raft organization (GO:0031579) | 2.72209547 |
111 | positive regulation of lipid kinase activity (GO:0090218) | 2.71086483 |
112 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.70715157 |
113 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.70188665 |
114 | gland morphogenesis (GO:0022612) | 2.69479050 |
115 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.69185571 |
116 | hormone catabolic process (GO:0042447) | 2.68763647 |
117 | regulation of sarcomere organization (GO:0060297) | 2.68566529 |
118 | negative regulation of blood coagulation (GO:0030195) | 2.67979449 |
119 | negative regulation of hemostasis (GO:1900047) | 2.67979449 |
120 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.67751263 |
121 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.66808150 |
122 | positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862) | 2.66047199 |
123 | establishment of endothelial barrier (GO:0061028) | 2.65132221 |
124 | negative regulation of epithelial cell migration (GO:0010633) | 2.64702788 |
125 | positive regulation of blood coagulation (GO:0030194) | 2.61776944 |
126 | positive regulation of hemostasis (GO:1900048) | 2.61776944 |
127 | gap junction assembly (GO:0016264) | 2.61374072 |
128 | regulation of cholesterol storage (GO:0010885) | 2.60550031 |
129 | low-density lipoprotein particle clearance (GO:0034383) | 2.59719885 |
130 | adhesion of symbiont to host (GO:0044406) | 2.59679794 |
131 | regulation of complement activation (GO:0030449) | 2.58821383 |
132 | positive regulation of endothelial cell migration (GO:0010595) | 2.58566681 |
133 | regulation of protein activation cascade (GO:2000257) | 2.58119279 |
134 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.54485055 |
135 | exogenous drug catabolic process (GO:0042738) | 2.54036766 |
136 | blood vessel morphogenesis (GO:0048514) | 2.53784510 |
137 | protein kinase C signaling (GO:0070528) | 2.53498256 |
138 | angiogenesis (GO:0001525) | 2.52367083 |
139 | ganglion development (GO:0061548) | 2.52005606 |
140 | regulation of vascular permeability (GO:0043114) | 2.51671592 |
141 | complement activation, alternative pathway (GO:0006957) | 2.51035801 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.37422697 |
2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.26302028 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.09310293 |
4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.73991803 |
5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.44842459 |
6 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 3.43332995 |
7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.88417828 |
8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.82927958 |
9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.78567826 |
10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.74522346 |
11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.41205964 |
12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.39368049 |
13 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.23304527 |
14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.16749135 |
15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.04348619 |
16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.00031957 |
17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.99888359 |
18 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.98652099 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91030033 |
20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.90401884 |
21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90346857 |
22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.89579157 |
23 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.81571998 |
24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.77759178 |
25 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.72213543 |
26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.71954346 |
27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66965859 |
28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.65383077 |
29 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.62573177 |
30 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.62573177 |
31 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56718240 |
32 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.56385910 |
33 | CJUN_26792858_Chip-Seq_BT549_Human | 1.55203539 |
34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54745870 |
35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52208643 |
36 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.50511516 |
37 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.49949059 |
38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.49289170 |
39 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.47042700 |
40 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.45160195 |
41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.43329613 |
42 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.42803469 |
43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41081876 |
44 | GATA1_19941826_ChIP-Seq_K562_Human | 1.39859890 |
45 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.36941579 |
46 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.35559060 |
47 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.34317311 |
48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.30304400 |
49 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29363851 |
50 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.28450478 |
51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24813866 |
52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24566754 |
53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23614271 |
54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.23339916 |
55 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.21520906 |
56 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.20527166 |
57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19904969 |
58 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.17257105 |
59 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13721675 |
60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12527203 |
61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12161415 |
62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12161415 |
63 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.11807139 |
64 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.11799331 |
65 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.11573262 |
66 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.11272051 |
67 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10879335 |
68 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.09542581 |
69 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.09431307 |
70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09349834 |
71 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.08410471 |
72 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07759278 |
73 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06888244 |
74 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06040201 |
75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05779943 |
76 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02898139 |
77 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02112686 |
78 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02112686 |
79 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.01367673 |
80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00329068 |
81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00222410 |
82 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99379814 |
83 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98558634 |
84 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97745969 |
85 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97711857 |
86 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.96927654 |
87 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.96927654 |
88 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.95980838 |
89 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95818363 |
90 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.95662839 |
91 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.94344481 |
92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93801449 |
93 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.92675370 |
94 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91565401 |
95 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.91497029 |
96 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.90888940 |
97 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89315164 |
98 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.89013055 |
99 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.89005342 |
100 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.88509874 |
101 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.87686760 |
102 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87522568 |
103 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87135728 |
104 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.87019556 |
105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86932463 |
106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86227668 |
107 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.86007462 |
108 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85577352 |
109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85555141 |
110 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85513591 |
111 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.85362731 |
112 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.85362731 |
113 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.85362731 |
114 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.85137569 |
115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84871115 |
116 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84867896 |
117 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.84551296 |
118 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.84479474 |
119 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.84374706 |
120 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.83922953 |
121 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.82941084 |
122 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.82389575 |
123 | RXR_22108803_ChIP-Seq_LS180_Human | 0.81493069 |
124 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81203062 |
125 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.80434970 |
126 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.79777717 |
127 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78192045 |
128 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.76736922 |
129 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.76540786 |
130 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.75746897 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010368_abnormal_lymphatic_system | 7.86634084 |
2 | MP0001879_abnormal_lymphatic_vessel | 5.84253855 |
3 | MP0005167_abnormal_blood-brain_barrier | 4.46548108 |
4 | MP0004272_abnormal_basement_membrane | 4.34449226 |
5 | MP0005360_urolithiasis | 3.86939876 |
6 | MP0003191_abnormal_cellular_cholesterol | 3.37491097 |
7 | MP0003705_abnormal_hypodermis_morpholog | 3.17119252 |
8 | MP0002138_abnormal_hepatobiliary_system | 3.16919408 |
9 | MP0003724_increased_susceptibility_to | 3.09626974 |
10 | MP0003828_pulmonary_edema | 2.95801182 |
11 | MP0004782_abnormal_surfactant_physiolog | 2.26549215 |
12 | MP0003950_abnormal_plasma_membrane | 2.25557650 |
13 | MP0004084_abnormal_cardiac_muscle | 2.22702838 |
14 | MP0009780_abnormal_chondrocyte_physiolo | 2.20433955 |
15 | MP0001958_emphysema | 2.14108917 |
16 | MP0002332_abnormal_exercise_endurance | 2.10805570 |
17 | MP0006138_congestive_heart_failure | 2.06872494 |
18 | MP0006054_spinal_hemorrhage | 2.06273658 |
19 | MP0000767_abnormal_smooth_muscle | 2.02110288 |
20 | MP0008875_abnormal_xenobiotic_pharmacok | 1.97740002 |
21 | MP0002139_abnormal_hepatobiliary_system | 1.84721635 |
22 | MP0004145_abnormal_muscle_electrophysio | 1.77437066 |
23 | MP0005165_increased_susceptibility_to | 1.68409396 |
24 | MP0002933_joint_inflammation | 1.67644732 |
25 | MP0005595_abnormal_vascular_smooth | 1.62884028 |
26 | MP0003279_aneurysm | 1.54262743 |
27 | MP0005085_abnormal_gallbladder_physiolo | 1.52417319 |
28 | MP0002295_abnormal_pulmonary_circulatio | 1.50613838 |
29 | MP0008438_abnormal_cutaneous_collagen | 1.46883300 |
30 | MP0003566_abnormal_cell_adhesion | 1.46063970 |
31 | MP0000249_abnormal_blood_vessel | 1.45308631 |
32 | MP0004883_abnormal_blood_vessel | 1.39310274 |
33 | MP0000013_abnormal_adipose_tissue | 1.38226621 |
34 | MP0005385_cardiovascular_system_phenoty | 1.36266328 |
35 | MP0001544_abnormal_cardiovascular_syste | 1.36266328 |
36 | MP0005365_abnormal_bile_salt | 1.34690521 |
37 | MP0000343_altered_response_to | 1.34024478 |
38 | MP0005164_abnormal_response_to | 1.27749673 |
39 | MP0004036_abnormal_muscle_relaxation | 1.26289188 |
40 | MP0003252_abnormal_bile_duct | 1.23935157 |
41 | MP0000465_gastrointestinal_hemorrhage | 1.23361781 |
42 | MP0003868_abnormal_feces_composition | 1.22547944 |
43 | MP0010030_abnormal_orbit_morphology | 1.21862484 |
44 | MP0002128_abnormal_blood_circulation | 1.20933078 |
45 | MP0003300_gastrointestinal_ulcer | 1.20125781 |
46 | MP0002877_abnormal_melanocyte_morpholog | 1.17378060 |
47 | MP0004215_abnormal_myocardial_fiber | 1.16976010 |
48 | MP0004147_increased_porphyrin_level | 1.12671349 |
49 | MP0003045_fibrosis | 1.12671164 |
50 | MP0005388_respiratory_system_phenotype | 1.12060511 |
51 | MP0002133_abnormal_respiratory_system | 1.12060511 |
52 | MP0004233_abnormal_muscle_weight | 1.10924491 |
53 | MP0005670_abnormal_white_adipose | 1.10508766 |
54 | MP0002925_abnormal_cardiovascular_devel | 1.10294465 |
55 | MP0003091_abnormal_cell_migration | 1.08352100 |
56 | MP0001614_abnormal_blood_vessel | 1.06952498 |
57 | MP0010329_abnormal_lipoprotein_level | 1.06881525 |
58 | MP0000749_muscle_degeneration | 1.03867835 |
59 | MP0008775_abnormal_heart_ventricle | 1.02340334 |
60 | MP0005275_abnormal_skin_tensile | 1.01718888 |
61 | MP0000003_abnormal_adipose_tissue | 0.99033304 |
62 | MP0005330_cardiomyopathy | 0.95291712 |
63 | MP0004130_abnormal_muscle_cell | 0.94052145 |
64 | MP0009840_abnormal_foam_cell | 0.91905338 |
65 | MP0001849_ear_inflammation | 0.91762515 |
66 | MP0000230_abnormal_systemic_arterial | 0.91684604 |
67 | MP0010630_abnormal_cardiac_muscle | 0.90078483 |
68 | MP0002972_abnormal_cardiac_muscle | 0.89734159 |
69 | MP0002106_abnormal_muscle_physiology | 0.88422578 |
70 | MP0002127_abnormal_cardiovascular_syste | 0.87492005 |
71 | MP0003567_abnormal_fetal_cardiomyocyte | 0.86942753 |
72 | MP0003303_peritoneal_inflammation | 0.86761157 |
73 | MP0002108_abnormal_muscle_morphology | 0.86606322 |
74 | MP0009764_decreased_sensitivity_to | 0.86238085 |
75 | MP0004085_abnormal_heartbeat | 0.85063803 |
76 | MP0005084_abnormal_gallbladder_morpholo | 0.84744593 |
77 | MP0004484_altered_response_of | 0.82962916 |
78 | MP0000751_myopathy | 0.81857560 |
79 | MP0005023_abnormal_wound_healing | 0.81475498 |
80 | MP0008004_abnormal_stomach_pH | 0.80236384 |
81 | MP0001915_intracranial_hemorrhage | 0.79715316 |
82 | MP0000759_abnormal_skeletal_muscle | 0.78307625 |
83 | MP0005369_muscle_phenotype | 0.77651800 |
84 | MP0000266_abnormal_heart_morphology | 0.75521876 |
85 | MP0003646_muscle_fatigue | 0.74614269 |
86 | MP0004510_myositis | 0.74471248 |
87 | MP0005083_abnormal_biliary_tract | 0.74272909 |
88 | MP0005375_adipose_tissue_phenotype | 0.74171998 |
89 | MP0003075_altered_response_to | 0.73865257 |
90 | MP0009278_abnormal_bone_marrow | 0.71258299 |
91 | MP0001851_eye_inflammation | 0.69558585 |
92 | MP0009643_abnormal_urine_homeostasis | 0.69239551 |
93 | MP0000537_abnormal_urethra_morphology | 0.69131305 |
94 | MP0001175_abnormal_lung_morphology | 0.68813693 |
95 | MP0001542_abnormal_bone_strength | 0.68384885 |
96 | MP0005620_abnormal_muscle_contractility | 0.66015050 |
97 | MP0002168_other_aberrant_phenotype | 0.64350558 |
98 | MP0001784_abnormal_fluid_regulation | 0.64244272 |
99 | MP0005623_abnormal_meninges_morphology | 0.63876454 |
100 | MP0009697_abnormal_copulation | 0.61101640 |
101 | MP0001853_heart_inflammation | 0.59777701 |
102 | MP0000733_abnormal_muscle_development | 0.59768194 |
103 | MP0003941_abnormal_skin_development | 0.59695898 |
104 | MP0005187_abnormal_penis_morphology | 0.59231799 |
105 | MP0000747_muscle_weakness | 0.59191929 |
106 | MP0000609_abnormal_liver_physiology | 0.59124693 |
107 | MP0003943_abnormal_hepatobiliary_system | 0.58808906 |
108 | MP0003385_abnormal_body_wall | 0.58675314 |
109 | MP0003948_abnormal_gas_homeostasis | 0.58409161 |
110 | MP0005503_abnormal_tendon_morphology | 0.57076719 |
111 | MP0002118_abnormal_lipid_homeostasis | 0.56682719 |
112 | MP0005409_darkened_coat_color | 0.56637592 |
113 | MP0004087_abnormal_muscle_fiber | 0.56159431 |
114 | MP0003984_embryonic_growth_retardation | 0.55811062 |
115 | MP0002088_abnormal_embryonic_growth/wei | 0.54982020 |
116 | MP0001756_abnormal_urination | 0.54781679 |
117 | MP0000750_abnormal_muscle_regeneration | 0.54109365 |
118 | MP0005319_abnormal_enzyme/_coenzyme | 0.53694975 |
119 | MP0002896_abnormal_bone_mineralization | 0.53533005 |
120 | MP0008995_early_reproductive_senescence | 0.53237509 |
121 | MP0001533_abnormal_skeleton_physiology | 0.53081519 |
122 | MP0005058_abnormal_lysosome_morphology | 0.52990642 |
123 | MP0005332_abnormal_amino_acid | 0.52650694 |
124 | MP0003935_abnormal_craniofacial_develop | 0.50915794 |
125 | MP0005166_decreased_susceptibility_to | 0.50077318 |
126 | MP0000467_abnormal_esophagus_morphology | 0.50061831 |
127 | MP0000613_abnormal_salivary_gland | 0.49742643 |
128 | MP0005376_homeostasis/metabolism_phenot | 0.49439265 |
129 | MP0003638_abnormal_response/metabolism_ | 0.48456090 |
130 | MP0010352_gastrointestinal_tract_polyps | 0.47420532 |
131 | MP0002086_abnormal_extraembryonic_tissu | 0.47015378 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Polycythemia (HP:0001901) | 7.48595955 |
2 | Spontaneous hematomas (HP:0007420) | 6.80907915 |
3 | Hematochezia (HP:0002573) | 6.69139612 |
4 | Deep venous thrombosis (HP:0002625) | 5.62022596 |
5 | Esophageal varix (HP:0002040) | 5.33717226 |
6 | Cerebral hemorrhage (HP:0001342) | 4.74933085 |
7 | Abnormality of the nasal mucosa (HP:0000433) | 4.72756572 |
8 | Conjunctival telangiectasia (HP:0000524) | 4.69063748 |
9 | Wrist flexion contracture (HP:0001239) | 4.61319503 |
10 | Visceral angiomatosis (HP:0100761) | 4.15878174 |
11 | Nonimmune hydrops fetalis (HP:0001790) | 4.00857365 |
12 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 4.00733379 |
13 | Cerebral aneurysm (HP:0004944) | 3.92816767 |
14 | Growth hormone excess (HP:0000845) | 3.89584058 |
15 | Hemangiomatosis (HP:0007461) | 3.87591247 |
16 | Interstitial pulmonary disease (HP:0006530) | 3.72699475 |
17 | Spinal rigidity (HP:0003306) | 3.63318459 |
18 | Myotonia (HP:0002486) | 3.61146989 |
19 | Mucosal telangiectasiae (HP:0100579) | 3.52383776 |
20 | Lymphangioma (HP:0100764) | 3.46505168 |
21 | Difficulty running (HP:0009046) | 3.43190586 |
22 | Broad metatarsal (HP:0001783) | 3.43173932 |
23 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.40170785 |
24 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.15047166 |
25 | Muscle fiber inclusion bodies (HP:0100299) | 3.14583454 |
26 | Nemaline bodies (HP:0003798) | 3.14109573 |
27 | Cavernous hemangioma (HP:0001048) | 3.10456724 |
28 | Portal hypertension (HP:0001409) | 3.05458100 |
29 | Hemorrhage of the eye (HP:0011885) | 2.94723319 |
30 | Hyperactive renin-angiotensin system (HP:0000841) | 2.92148991 |
31 | Distal lower limb muscle weakness (HP:0009053) | 2.90166047 |
32 | Joint hemorrhage (HP:0005261) | 2.90086428 |
33 | Microcytic anemia (HP:0001935) | 2.89000524 |
34 | Camptodactyly of toe (HP:0001836) | 2.83724944 |
35 | Difficulty climbing stairs (HP:0003551) | 2.83479168 |
36 | Premature rupture of membranes (HP:0001788) | 2.83280503 |
37 | Pulmonary hypertension (HP:0002092) | 2.78464723 |
38 | Type 1 muscle fiber predominance (HP:0003803) | 2.76473357 |
39 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.76388711 |
40 | Round ear (HP:0100830) | 2.75675104 |
41 | Abnormality of the intrinsic pathway (HP:0010989) | 2.73958228 |
42 | Asymmetric septal hypertrophy (HP:0001670) | 2.73300336 |
43 | Potter facies (HP:0002009) | 2.71400999 |
44 | Facial shape deformation (HP:0011334) | 2.71400999 |
45 | Abnormality of the hepatic vasculature (HP:0006707) | 2.70504517 |
46 | Complement deficiency (HP:0004431) | 2.67843633 |
47 | Overgrowth (HP:0001548) | 2.65546873 |
48 | Aneurysm (HP:0002617) | 2.62765427 |
49 | Stroke (HP:0001297) | 2.59862083 |
50 | Aortic aneurysm (HP:0004942) | 2.59705589 |
51 | Intrahepatic cholestasis (HP:0001406) | 2.57750031 |
52 | Chondrocalcinosis (HP:0000934) | 2.57472651 |
53 | Hip contracture (HP:0003273) | 2.50057086 |
54 | Protrusio acetabuli (HP:0003179) | 2.49771161 |
55 | Hypercholesterolemia (HP:0003124) | 2.47831047 |
56 | Pulmonary embolism (HP:0002204) | 2.47683091 |
57 | Hypoplasia of the iris (HP:0007676) | 2.46225604 |
58 | EMG: myopathic abnormalities (HP:0003458) | 2.44867334 |
59 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.42579097 |
60 | Abnormality of Sharpey fibers (HP:0100685) | 2.39455797 |
61 | Right ventricular cardiomyopathy (HP:0011663) | 2.37174593 |
62 | Menorrhagia (HP:0000132) | 2.36053597 |
63 | Aortic valve stenosis (HP:0001650) | 2.31135804 |
64 | Increased connective tissue (HP:0009025) | 2.30632830 |
65 | Thrombophlebitis (HP:0004418) | 2.27303852 |
66 | Cardiovascular calcification (HP:0011915) | 2.25115718 |
67 | Distal arthrogryposis (HP:0005684) | 2.24744717 |
68 | Joint contractures involving the joints of the feet (HP:0100492) | 2.23476688 |
69 | Flexion contracture of toe (HP:0005830) | 2.23476688 |
70 | Acanthosis nigricans (HP:0000956) | 2.22912554 |
71 | Xanthomatosis (HP:0000991) | 2.21739798 |
72 | Striae distensae (HP:0001065) | 2.21692299 |
73 | Exercise-induced myalgia (HP:0003738) | 2.20209325 |
74 | Supraventricular arrhythmia (HP:0005115) | 2.20078203 |
75 | Pulmonary artery stenosis (HP:0004415) | 2.19599715 |
76 | Venous insufficiency (HP:0005293) | 2.18845340 |
77 | Bone cyst (HP:0012062) | 2.18325379 |
78 | Ventricular tachycardia (HP:0004756) | 2.18297478 |
79 | Vascular calcification (HP:0004934) | 2.14803860 |
80 | Vascular tortuosity (HP:0004948) | 2.12178374 |
81 | Limited hip movement (HP:0008800) | 2.11990384 |
82 | Distal lower limb amyotrophy (HP:0008944) | 2.11504501 |
83 | Long toe (HP:0010511) | 2.11275597 |
84 | Hyperlipoproteinemia (HP:0010980) | 2.11191413 |
85 | Porencephaly (HP:0002132) | 2.10344459 |
86 | Muscle fiber splitting (HP:0003555) | 2.09496138 |
87 | Hypoglycemic coma (HP:0001325) | 2.07965437 |
88 | Abnormality of the common coagulation pathway (HP:0010990) | 2.07957735 |
89 | Neonatal death (HP:0003811) | 2.07388994 |
90 | Amyloidosis (HP:0011034) | 2.06806172 |
91 | Cervical subluxation (HP:0003308) | 2.05828119 |
92 | Atrioventricular block (HP:0001678) | 2.05485362 |
93 | Adactyly (HP:0009776) | 2.03576711 |
94 | Arterial tortuosity (HP:0005116) | 2.03374278 |
95 | Glucose intolerance (HP:0000833) | 2.03093915 |
96 | Hyporeflexia of lower limbs (HP:0002600) | 2.02678762 |
97 | Exotropia (HP:0000577) | 2.02528074 |
98 | Atrial fibrillation (HP:0005110) | 2.02353226 |
99 | Aortic dissection (HP:0002647) | 2.02271660 |
100 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.02157352 |
101 | Venous abnormality (HP:0002624) | 2.01534373 |
102 | Sudden death (HP:0001699) | 2.01052507 |
103 | Ectopia lentis (HP:0001083) | 2.00809892 |
104 | Areflexia of lower limbs (HP:0002522) | 2.00731858 |
105 | Hydroureter (HP:0000072) | 2.00501763 |
106 | Short hallux (HP:0010109) | 1.95810125 |
107 | Broad face (HP:0000283) | 1.94433839 |
108 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.93840443 |
109 | Short 4th metacarpal (HP:0010044) | 1.93840443 |
110 | Impaired platelet aggregation (HP:0003540) | 1.93291177 |
111 | Abnormal platelet function (HP:0011869) | 1.93291177 |
112 | Abnormal atrioventricular conduction (HP:0005150) | 1.91847820 |
113 | Wormian bones (HP:0002645) | 1.91812491 |
114 | Myocardial infarction (HP:0001658) | 1.91811133 |
115 | Prolonged partial thromboplastin time (HP:0003645) | 1.91793132 |
116 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.91494421 |
117 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.91494421 |
118 | Single umbilical artery (HP:0001195) | 1.91494421 |
119 | Pigmentary retinal degeneration (HP:0001146) | 1.91403974 |
120 | Neck muscle weakness (HP:0000467) | 1.91228299 |
121 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.88968821 |
122 | Vertebral clefting (HP:0008428) | 1.88898117 |
123 | Hypoalphalipoproteinemia (HP:0003233) | 1.88212284 |
124 | Skull defect (HP:0001362) | 1.88142683 |
125 | Blue sclerae (HP:0000592) | 1.87449804 |
126 | Asymmetry of the thorax (HP:0001555) | 1.87074527 |
127 | Mitral valve prolapse (HP:0001634) | 1.86595956 |
128 | Abnormal vertebral ossification (HP:0100569) | 1.86307090 |
129 | Mitral stenosis (HP:0001718) | 1.85171604 |
130 | Increased variability in muscle fiber diameter (HP:0003557) | 1.84982078 |
131 | Joint stiffness (HP:0001387) | 1.84534268 |
132 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.83326036 |
133 | Heart block (HP:0012722) | 1.82029170 |
134 | Chronic bronchitis (HP:0004469) | 1.81987488 |
135 | Large hands (HP:0001176) | 1.81690959 |
136 | High pitched voice (HP:0001620) | 1.81634232 |
137 | Disproportionate tall stature (HP:0001519) | 1.80150946 |
138 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.79229368 |
139 | Hypotension (HP:0002615) | 1.78411256 |
140 | Abnormality of complement system (HP:0005339) | 1.77762395 |
141 | Nephritis (HP:0000123) | 1.76730506 |
142 | Cerebral palsy (HP:0100021) | 1.76457275 |
143 | Intestinal polyposis (HP:0200008) | 1.75754145 |
144 | Shallow orbits (HP:0000586) | 1.75182412 |
145 | Tetraparesis (HP:0002273) | 1.74183197 |
146 | Capillary hemangiomas (HP:0005306) | 1.73569710 |
147 | Hemiplegia (HP:0002301) | 1.72847540 |
148 | Absent hand (HP:0004050) | 1.72669530 |
149 | Lipoatrophy (HP:0100578) | 1.71949889 |
150 | Abnormal glucose tolerance (HP:0001952) | 1.70342014 |
Rank | Gene Set | Z-score |
---|---|---|
1 | KDR | 6.77534782 |
2 | TGFBR2 | 4.40174696 |
3 | TGFBR1 | 2.87031173 |
4 | EPHB2 | 2.27377297 |
5 | TIE1 | 11.1985131 |
6 | RIPK1 | 1.99463499 |
7 | ERN1 | 1.90085582 |
8 | PTK2B | 1.78246526 |
9 | EPHB1 | 1.77073185 |
10 | GRK1 | 1.73749156 |
11 | FGFR4 | 1.72674394 |
12 | FER | 1.54866502 |
13 | PTK6 | 1.50972418 |
14 | MYLK | 1.47034922 |
15 | TRIB3 | 1.31436617 |
16 | PAK4 | 1.23414424 |
17 | PDGFRA | 1.22451750 |
18 | MAP2K3 | 1.19142212 |
19 | PKN2 | 1.08382002 |
20 | LRRK2 | 1.03000100 |
21 | EPHA3 | 1.02333066 |
22 | TTN | 0.96178312 |
23 | FGFR2 | 0.95050510 |
24 | NTRK1 | 0.94197329 |
25 | CSK | 0.92893930 |
26 | MAP3K3 | 0.90769062 |
27 | DMPK | 0.88466425 |
28 | PRKG2 | 0.86822353 |
29 | FGFR3 | 0.85684171 |
30 | BCKDK | 0.85201667 |
31 | NEK9 | 0.83271737 |
32 | STK10 | 0.81264753 |
33 | PTK2 | 0.80735463 |
34 | TRPM7 | 0.79513255 |
35 | EEF2K | 0.78921176 |
36 | INSRR | 0.77944114 |
37 | LATS1 | 0.77562973 |
38 | BMPR1B | 0.72854857 |
39 | PRKD1 | 0.70119335 |
40 | MET | 0.64428364 |
41 | SIK1 | 0.62144366 |
42 | JAK1 | 0.61559094 |
43 | CDK8 | 0.61425916 |
44 | MAPK12 | 0.57670686 |
45 | PDK2 | 0.55914180 |
46 | MOS | 0.55854448 |
47 | TEC | 0.55272956 |
48 | PRKCH | 0.54215147 |
49 | AKT3 | 0.50861734 |
50 | TYK2 | 0.49930315 |
51 | MAP3K7 | 0.49351666 |
52 | PDGFRB | 0.49068649 |
53 | ARAF | 0.48012679 |
54 | RET | 0.47238382 |
55 | GSK3A | 0.46699161 |
56 | JAK2 | 0.46288617 |
57 | ITK | 0.45270997 |
58 | EGFR | 0.44757053 |
59 | MAP3K1 | 0.44553836 |
60 | MAPK15 | 0.44297061 |
61 | MST4 | 0.43941528 |
62 | ILK | 0.42373331 |
63 | TESK1 | 0.40872913 |
64 | IGF1R | 0.39606242 |
65 | SRC | 0.38818997 |
66 | PRKAA2 | 0.38552941 |
67 | LMTK2 | 0.38271267 |
68 | TBK1 | 0.37897322 |
69 | BCR | 0.35784800 |
70 | HCK | 0.34872729 |
71 | DAPK2 | 0.34765040 |
72 | PDPK1 | 0.34568863 |
73 | DDR2 | 0.33058304 |
74 | RPS6KA2 | 0.33054096 |
75 | MAPKAPK3 | 0.32621925 |
76 | PIK3CG | 0.31448996 |
77 | JAK3 | 0.31309650 |
78 | MAP3K11 | 0.31255824 |
79 | MAP3K13 | 0.30446801 |
80 | IRAK3 | 0.30236100 |
81 | CDK9 | 0.29734466 |
82 | CAMK4 | 0.29151556 |
83 | ROCK1 | 0.28680698 |
84 | PRKD3 | 0.27698449 |
85 | MAP2K1 | 0.26241539 |
86 | INSR | 0.26020303 |
87 | ZAP70 | 0.25879312 |
88 | LIMK1 | 0.25639900 |
89 | MARK3 | 0.25346920 |
90 | STK3 | 0.25149784 |
91 | GRK7 | 0.24296896 |
92 | FGFR1 | 0.23562589 |
93 | ABL1 | 0.23138528 |
94 | MAPK4 | 0.22737950 |
95 | MAPKAPK5 | 0.21725978 |
96 | CAMK1D | 0.21519113 |
97 | MAPK7 | 0.21141503 |
98 | PAK2 | 0.20956593 |
99 | LATS2 | 0.20522353 |
100 | MAP2K2 | 0.20340561 |
101 | FLT3 | 0.20237606 |
102 | CDK6 | 0.20224606 |
103 | NLK | 0.20218179 |
104 | PAK3 | 0.19852281 |
105 | PHKG1 | 0.18933644 |
106 | PHKG2 | 0.18933644 |
107 | ABL2 | 0.17406481 |
108 | MST1R | 0.16818392 |
109 | KIT | 0.16609187 |
110 | PRKCE | 0.16401837 |
111 | PRKD2 | 0.16307726 |
112 | FES | 0.16204155 |
113 | MARK2 | 0.15761176 |
114 | BTK | 0.15156133 |
115 | ROCK2 | 0.14695139 |
116 | GRK5 | 0.14546115 |
117 | MAP3K6 | 0.14388767 |
118 | OBSCN | 0.14376459 |
119 | DAPK3 | 0.13473892 |
120 | PIK3CA | 0.12966848 |
121 | MAP3K2 | 0.12149943 |
122 | EPHA2 | 0.11585304 |
123 | CDC42BPA | 0.10153147 |
124 | AKT2 | 0.10128571 |
125 | MTOR | 0.09665704 |
126 | LCK | 0.08559359 |
127 | ERBB4 | 0.07540016 |
128 | PRKAA1 | 0.07164554 |
129 | PAK6 | 0.07132857 |
130 | SCYL2 | 0.05431889 |
131 | FYN | 0.05149486 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.18121110 |
2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.01201503 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.62124497 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.53184191 |
5 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.45461814 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29529476 |
7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.17560337 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16241375 |
9 | Focal adhesion_Homo sapiens_hsa04510 | 2.11396281 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.09084674 |
11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.02564181 |
12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81825628 |
13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.74844123 |
14 | Bile secretion_Homo sapiens_hsa04976 | 1.71426236 |
15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.68404830 |
16 | Adherens junction_Homo sapiens_hsa04520 | 1.66576470 |
17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.62487674 |
18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.60859872 |
19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.57509319 |
20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.44272861 |
21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.35802342 |
22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.35017541 |
23 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.30634916 |
24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.29331376 |
25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.28880101 |
26 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.26893923 |
27 | Malaria_Homo sapiens_hsa05144 | 1.24843960 |
28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.24186194 |
29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.23967765 |
30 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.19700824 |
31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.18125691 |
32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.17488034 |
33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16890549 |
34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.15745988 |
35 | Amoebiasis_Homo sapiens_hsa05146 | 1.15634395 |
36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13250805 |
37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.12620064 |
38 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.11991068 |
39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10647702 |
40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.10225837 |
41 | Platelet activation_Homo sapiens_hsa04611 | 1.08468404 |
42 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.07529426 |
43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04071350 |
44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03961966 |
45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.03954996 |
46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03609987 |
47 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.01597533 |
48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01402546 |
49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00011014 |
50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98658497 |
51 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.96675243 |
52 | Insulin resistance_Homo sapiens_hsa04931 | 0.94114362 |
53 | Tight junction_Homo sapiens_hsa04530 | 0.93456325 |
54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.93164254 |
55 | Peroxisome_Homo sapiens_hsa04146 | 0.91140913 |
56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90982015 |
57 | ABC transporters_Homo sapiens_hsa02010 | 0.90948221 |
58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89856478 |
59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86213534 |
60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86022665 |
61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.85399503 |
62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.82462544 |
63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81985066 |
64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81333096 |
65 | Renin secretion_Homo sapiens_hsa04924 | 0.78996004 |
66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78460467 |
67 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78184011 |
68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78099929 |
69 | Axon guidance_Homo sapiens_hsa04360 | 0.76276872 |
70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75224961 |
71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73272796 |
72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72695031 |
73 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.71902905 |
74 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70156033 |
75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69931489 |
76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69868993 |
77 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.69498746 |
78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67585069 |
79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66228543 |
80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65644652 |
81 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.65193231 |
82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63915111 |
83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63633327 |
84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63222696 |
85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60290045 |
86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59666048 |
87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59347733 |
88 | Melanogenesis_Homo sapiens_hsa04916 | 0.57281191 |
89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57059283 |
90 | Endocytosis_Homo sapiens_hsa04144 | 0.57036889 |
91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56769226 |
92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54944419 |
93 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54648638 |
94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53747775 |
95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52671304 |
96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50868660 |
97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50868426 |
98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50357877 |
99 | Prion diseases_Homo sapiens_hsa05020 | 0.49773498 |
100 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.49609365 |
101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49536473 |
102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49001549 |
103 | Salmonella infection_Homo sapiens_hsa05132 | 0.48950539 |
104 | Pertussis_Homo sapiens_hsa05133 | 0.47160091 |
105 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46791372 |
106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46779094 |
107 | Lysine degradation_Homo sapiens_hsa00310 | 0.46396977 |
108 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.45753733 |
109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44671462 |
110 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.44279357 |
111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43871101 |
112 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.43691842 |
113 | Shigellosis_Homo sapiens_hsa05131 | 0.43598900 |
114 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42941233 |
115 | Gap junction_Homo sapiens_hsa04540 | 0.42921540 |
116 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42075247 |
117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41750302 |
118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41125804 |
119 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40808313 |
120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40436182 |
121 | Glioma_Homo sapiens_hsa05214 | 0.40411872 |
122 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39253761 |
123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39166505 |
124 | Hepatitis C_Homo sapiens_hsa05160 | 0.38179720 |
125 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37784836 |
126 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.36879842 |
127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36729606 |
128 | Lysosome_Homo sapiens_hsa04142 | 0.35346173 |
129 | Bladder cancer_Homo sapiens_hsa05219 | 0.35140258 |
130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34810077 |
131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34007696 |
132 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.33317737 |
133 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33209679 |
134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33172646 |
135 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.33110449 |
136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32823078 |
137 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32329761 |